Severe asymptomatic hypertension: Ending the urgency of “hypertensive urgency”
Proceedings of Singapore Healthcare · 2026-05 · 35
DOI: 10.1177/20101058261451669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of Singapore Healthcare, online erschienen am 12.05.2026. Verfasst von Wai Lun Moy und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Severe asymptomatic hypertension (historically termed “hypertensive urgency”) is common in hospital settings and is frequently overtreated. In the absence of acute target organ damage, aggressive short-term blood pressure reduction or parenteral therapy is not recommended. Many patients experience spontaneous decline in blood pressure with rest. In fact, observational studies in non-cardiac inpatients link antihypertensive intensification to increased risk of hypoperfusion to the vital organs. We present a real case illustrating harm from rapid multi-drug stacking and then review a practical approach to management. In line with the latest AHA/ACC 2025 Hypertension Guidelines, we urge all medical practitioners to retire the emotive label of “hypertensive urgency” and adopt “severe asymptomatic hypertension” which better reflects the evidence.
Zitieren
APA
Moy, W. L., & Aw, D. C. W. (2026). Severe asymptomatic hypertension: Ending the urgency of “hypertensive urgency”. Proceedings of Singapore Healthcare, 35. https://doi.org/10.1177/20101058261451669
Vancouver
Moy WL, Aw DCW. Severe asymptomatic hypertension: Ending the urgency of “hypertensive urgency”. Proceedings of Singapore Healthcare. 2026;35. doi:10.1177/20101058261451669
BibTeX
@article{Moy2026,
author = {Moy, Wai Lun and Aw, Derrick Chen Wee},
title = {Severe asymptomatic hypertension: Ending the urgency of “hypertensive urgency”},
journal = {Proceedings of Singapore Healthcare},
year = {2026},
volume = {35},
doi = {10.1177/20101058261451669}
}
EUVIMED